サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：皮膚充填剤の世界市場 (ジェンダー別、材料別、エンドユーザー別、流通チャネル別、主要地域別)：産業動向と予測 (2023～2035年)
市場調査レポート
商品コード
1411404

皮膚充填剤の世界市場 (ジェンダー別、材料別、エンドユーザー別、流通チャネル別、主要地域別)：産業動向と予測 (2023～2035年)

Dermal Fillers Market, 2023-2035 - Distribution by Gender, by Material, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts
出版日: | 発行: Roots Analysis | ページ情報: 英文 234 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮膚充填剤の世界市場 (ジェンダー別、材料別、エンドユーザー別、流通チャネル別、主要地域別)：産業動向と予測 (2023～2035年)
出版日: 2024年01月06日
発行: Roots Analysis
ページ情報: 英文 234 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の皮膚充填剤市場は、2023年に30億米ドルと評価され、予測期間中 (2023～2035年) に9%のCAGRで成長します。

刻々と変化する医療美容の世界では、最新の動向に対応することが、開発者にとっても消費者にとっても優先事項となっています。皮膚充填剤 (ダーマルフィラー) は、ヒアルロン酸をゲル状物質の形で含む注射治療で、フェイシャルフィラーとも呼ばれます。皮膚充填剤は近年、顔の若返り、即効性のある顔のリフトアップ、傷跡の治療、唇の強化に関して、消費者の間で最も求められている選択肢の一つとなっています。IAPSによると、2022年には世界中で430万件以上のヒアルロン酸皮膚充填剤の処置が行われました。これは、この処置が低侵襲で、美容整形を求める多くの患者に適しているという事実によるところが大きいです。場合によっては、これらの処置は非侵襲的 (痛みがごく僅か、あるいは伴わない) こともあります。

皮膚充填剤は一般的に、ヒアルロン酸、乳酸、カルシウムハイドロキシアパタイト、ポリメチルメタクリル酸ゲルからできています。真皮充填剤は通常、顔の中でも鼻唇溝 (ほうれい線)・マリオネットライン・頬、口交連といった部位の皮下に注入されます。治療には麻酔は必要ありません。治療期間は、使用する材料にもよりますが5ヶ月から5年です。科学者たちは、カニューレ・テクニックを使用することで、皮膚充填剤市場に革命を起こしています。カニューレ・テクニックでは、処置の侵襲性を低減し、あざを最小限に抑え、充填剤の正確な配置を可能にします。技術進歩により、次世代の充填剤の開発も可能になりました。これらの充填剤はより優れた架橋特性を持ち、より長持ちする結果をもたらします。真皮充填剤治療の需要の高まりと、毎年真皮充填剤治療を必要とする患者の増加により、真皮充填剤注入市場は予測期間中に成長すると予想されます。

当レポートでは、世界の皮膚充填剤の市場について分析し、製品の概要や市場の基本構造・最新情勢、主な市場促進・抑制要因、全体的な市場規模の動向見通し、セグメント別・地域別 (全5地域) の詳細動向、昨今の主な事業提携・資本取引の動き (投資、M&Aなど)、現在の競合情勢、主要企業のプロファイルなどを調査しております。

主な市場区分

ジェンダー別

  • 男性
  • 女性

材料別

  • ヒアルロン酸充填剤
  • 非ヒアルロン酸充填剤

エンドユーザー別

  • 病院
  • クリニック/医療スパ、皮膚科/美容センター
  • その他のエンドユーザー

販売チャネル別

  • 直接販売
  • 間接販売

主要地域別

  • 北米 (米国、カナダ、メキシコ)
  • 欧州 (英国、ドイツ、フランス、イタリア、スペイン、その他)
  • アジア太平洋 (中国、韓国、日本、インド)
  • 中東・北アフリカ (トルコ、イラン、その他)
  • ラテンアメリカ (ブラジル、アルゼンチン、その他)

主な市場参入企業

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

目次

第1章 序論

第2章 調査手法

第3章 景気動向・その他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

  • 医療美学の概念
  • 医療美学の進化
  • 皮膚充填剤
  • 皮膚充填剤の利点
  • 皮膚充填剤の副作用
  • 医療美容の主な成長促進要因
  • 医療美容における最新技術
  • 医療美容の主な課題
  • 将来の展望

第6章 市場情勢

  • 皮膚充填剤：市場情勢

第7章 企業プロファイル

  • Allergan Aesthetics
  • Croma Pharma
  • Galderma
  • IBSA
  • Sinclair Pharma

第8章 企業競争力の分析

  • 主要な前提条件とパラメータ
  • 調査手法
  • 医療の美学：企業競争力の分析

第9章 パートナーシップとコラボレーション

  • パートナーシップモデル
  • 皮膚充填剤：パートナーシップとコラボレーション
  • 地域別の分析

第10章 資金調達と投資

  • 資金調達モデル
  • 皮膚充填剤：資金調達と投資
  • 結論

第11章 市場への影響分析：促進要因・抑制要因・機会・課題

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題
  • 結論

第12章 世界の皮膚充填剤市場

  • 主な前提条件と調査手法
  • 世界の皮膚充填剤市場：過去の動向 (2018～2022年) と今後の予測 (2023～2035年)
  • 主な市場区分
  • ダイナミックダッシュボード

第13章 皮膚充填剤市場、エンドユーザー別

  • 主な前提条件と調査手法
  • 皮膚充填剤市場：エンドユーザー別 (2018年、2023年、2035年)
  • データの計測と検証

第14章 皮膚充填剤市場：ジェンダー別

  • 主な前提条件と調査手法
  • 皮膚充填剤市場：ジェンダー別 (2018年、2023年、2035年)
  • データの計測と検証

第15章 皮膚充填剤市場、流通チャネル別

  • 主な前提条件と調査手法
  • 皮膚充填剤市場、流通チャネル別 (2018年、2023年、2035年)
  • データの計測と検証

第16章 皮膚充填剤市場：主要地域別

  • 主な前提条件と調査手法
  • 皮膚充填剤市場：主要地域別 (2018年、2023年、2035年)
  • データの計測と検証

第17章 皮膚充填剤製品市場

  • 主な前提条件と調査手法
  • 世界の皮膚充填剤製品市場：過去の動向 (2018～2022年) と今後の予測 (2023～2035年)
  • 皮膚充填剤製品市場：主要地域別 (2018年、2023年、2035年)
  • データの計測と検証

第18章 経営陣の洞察

第19章 結論

第20章 付録1：表形式のデータ

第21章 付録2：企業・組織の一覧

目次
Product Code: RA100471

The dermal fillers market is valued at USD 3 billion in 2023 growing at a CAGR of 9% during the forecast period 2023-2035.

In the ever-changing world of medical aesthetics, staying up to date with the latest trends has become a priority for both the developers and the consumers. Dermal fillers are injectable treatments that contain hyaluronic acids in the form of gel-like substances. They are also called facial fillers. In recent years, dermal fillers have become one of the most sought-after options among consumers when it comes to facial rejuvenation, instant facial lift, scar treatment, and lip enhancement. According to IAPS, in 2022, more than 4.3 million Hyaluronic acid Dermal Filler procedures were performed worldwide. This is largely due to the fact that the procedure is minimally invasive, making it suitable for a large number of patients seeking cosmetic procedures. In some cases, these procedures can be non-invasive, meaning they involve minimal or no pain.

Dermal fillers are generally made up of hyaluronic acids, lactic acids, calcium hydroxyapatite and polymethyl methacrylic acid gels. Dermal fillers are usually injected under the skin in the following areas of the face: nasolabial fold, marionette line, cheeks, oral commissures, etc. Treatment does not require anesthesia. The duration of the treatment can range from 5 months up to 5 years depending on the material used. Scientists are revolutionizing the field of Dermal Fillers market by using cannula technique. Cannula technique involves the use of a blunt tip cannula despite the presence of a needle for the injection of fillers. This approach reduces the invasive nature of the procedure, minimizes bruising, and allows for precise placement of fillers. Technological advances have also enabled the development of next generation fillers. These fillers have better cross-linking characteristics and provide longer lasting results. With the growing demand and increasing number of patients requiring dermal filler treatments every year, the dermal filler injection market is expected to grow over the forecast period.

Key Market Segments

Gender

  • Male
  • Female

Material

  • Hyaluronic Fillers
  • Non-Hyaluronic Acid Fillers

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, South Korea, Japan, India)
  • Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the dermal fillers market based on gender, material, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including dermal fillers, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of dermal filler developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering dermal filler procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of dermal filler company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics dermal fillers companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the dermal fillers market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Inclusions and Exclusions
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Ris
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Dermal Fillers
  • 5.5. Advantages of Dermal Fillers
  • 5.6. Side Effects of Dermal Fillers
  • 5.7. Key Growth Drivers of Medical Aesthetics
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Dermal Fillers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Application Area
    • 6.2.8. Analysis by End-user

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Allergan Aesthetics
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Medical Aesthetics Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Croma Pharma
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Medical Aesthetics Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Galderma
    • 7.4.1. Company Overview
    • 7.4.2. Financial Information
    • 7.4.3. Medical Aesthetics Portfolio
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. IBSA
    • 7.5.1. Company Overview
    • 7.5.2. Medical Aesthetics Portfolio
    • 7.5.3. Recent Developments and Future Outlook
  • 7.6. Sinclair Pharma
    • 7.6.1. Company Overview
    • 7.6.2. Medical Aesthetics Portfolio
    • 7.6.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Dermal Fillers: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Dermal Fillers: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.9. Analysis by Company Size and Amount Invested
    • 10.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL DERMAL FILLERS MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 12.3.1. Scenario Analysis
      • 12.3.1.1. Conservative Scenario Analysis
      • 12.3.1.2. Optimistic Scenario Analysis
  • 12.4. Key Market Segmentations
  • 12.5. Dynamic Dashboards

13. DERMAL FILLERS MARKET, BY END-USER

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035
    • 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

13.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 13.4. Data Triangulation and Validation

14. DERMAL FILLERS MARKET, BY GENDER

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035
    • 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Dermal Fillers Market, by Distribution Channel, 2015, 2023 and 2035
    • 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. DERMAL FILLERS MARKET, BY KEY GEOGRAPHICAL REGION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Dermal Fillers Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
    • 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. DERMAL FILLERS PRODUCT MARKET

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Dermal Fillers Products Market, by Key Geographical Regions, 2018, 2023 and 2035
    • 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXECUTIVE INSIGHTS

19. CONCLUSION

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS